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Abstract
In this work, we present a statistical and epidemiological analysis of the stroke incidence,
being currently the second leading cause of global death and cause of disability in adults
worldwide level. More particularly, we have analysed its recent trend up to 2014, for all
the socio-health care region in Lleida. This research project reveals a reasonably accurate
stroke current situation in Lleida, being this level of interest not only epidemiological but
also in terms of public health and proper adequacy of resources, economic and healthcare,
to face the diagnosis, treatment and prevention of this disease.
Regarding statistical methodology, we provide an efficient modeling frame to analyse inci-
dence data for a given disease, by means of age-period models. All the computation work
have been performed with R statistical package.
Keywords: Stroke, Incidence rate, Poisson models, Epidemiology, Annual Percent
Change, Lleida.
Resum
En aquest treball, presentem un ana`lisi estad´ıstic i epidemiolo`gic de la incide`ncia de
l’´ıctus que actualment e´s la segona causa de mort i de discapacitats en poblacio´ adulta
a nivell mundial. Me´s concretament, hem analitzat la seva tende`ncia fins al 2014 per a
la regio´ socio-sanita`ria de Lleida. Aquest projecte d’investigacio´ mostra la situacio´ actual
de l’´ıctus, de manera raonablement acurada a Lleida. L’intere`s d’aquest no nome´s e´s a
nivell epidemiolo`gic, sino´ tambe´ en termes de salut pu´blica i correcte gestio´ dels recursos
econo`mics i sanita`ris, per a fer front a les diagnosis, pel tractament i la prevencio´ de la
malaltia.
Pel que fa a la metodologia estad´ıstica, treballem en un marc eficient per analitzar dades
d’incide`ncia, donada una malaltia. S’han emprat models d’edat-per´ıode amb aquesta
finalitat. Tots els ca`lculs s’han realitzat emprant el paquet estad´ıstic R.
Paraules clau: I´ctus, Taxa d’Incide`ncia, Models de Poisson, Epidemiologia, Per-
centatge de canvi anual, Lleida.
Resumen
En este trabajo, se presenta un ana´lisis estad´ıstico i epidemiolo´gico de la incidencia del
ictus, siendo esta la segunda causa de muerte i de discapacidades en poblacio´n adulta a
nivel mundial. Ma´s concretamente, se han analizado las tendencias hasta el 2014 para la
regio´n sociosanitaria de Le´rida. Este proyecto de investigacio´n muestra la situacio´n actual
del ictus, de manera razonablente cuidadosa en Le´rida. El intere´s de este no solo es a nivel
epidemiolo´gico, sino tambie´n en te´rminos de salud pu´blica y una gestio´n de los recursos
econo´micos i sanitarios adecuados, para hacer frente al diagno´stico, para el tratamiento y
la prevencio´n de la enfermedad.
Respecto a la metodolog´ıa estad´ıstica, se ha trabajo en un marco eficiente para analizar
datos de incidencia, dada una enfermedad. Se han utilizado modelos edad-per´ıodo con
este objectivo. Todos los ca´lculos se han realizado con el paquete estad´ıstico R.
Palabras clave: Ictus, Tasa de Incidencia, Modelos de Poisson, Epidemiolog´ıa, Por-
centage de cambio anual, Le´rida.
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1 Preface
W hen most of the pople think about statistics, they tend to visualise it as a useless tool. In fact, peoplegets disconcerted when I introduce myself as a statistician. What it surprises me, is that they are not able
to see how important could be this field in our society. Statistics, in a nutshell, is the skill of understanding,
processing, exploring and eventually be able to summarise and understand the insights of any given data. These
days, I believe we live in the data age, where either the public and the private sector are generating an enormous
amounts of data. In this sense, I belive that statisticians will be able to make a great contribution.
I always thought, as an analogy, that statisticians are like journalists. I will explain, journalists are instructed
on communication skills, to be objectives, ... but they can apply all those things in such different areas.
Statisticians are taught on programming skills, quantitative vision, applied mathematics, ... but they can as
well apply all those things in many areas. In my case, I decided to start my professional career in biomedical
research. The work presented in this document, is the culmination of several months of my internship at the
Institut de Recerca Biome`dica de Lleida (IRBLleida)1 . During this time, I was working at the Unitat de
Bioestad´ıstica i Epidemiologia (UBE)2 and I have been involved in several biomedical research analysis with
different multidisciplinar groups.
Regarding the analysis be exposed on this document, it was headed by Dr. Francesc Purroy as principal
investigator and head of the Clinical Neuroscience group3 . Ana Bele´n Vena and Joan Valls were my mentors
in the medical and the methodological parts, correspondingly. The study, aims to describe the incidence of the
Stroke disease in Lleida. If I would be forced to sum up the whole work in two words I may choose: Stroke
and Epidemiology. Stroke, of course, is the disease which is the object of the study and is broadly known for
most of the population. Nevertheless, there are few studies that quantify the incidence or mortality in Spain.
Some recent studies have tried to collect data for the incidence of stroke in different countries. In that sense,
underdeveloped countries have less control on this matter, making much difficult to obtain a worlwide stroke
incidence estimation.
On the other hand, epidemiology,4 is the study and analysis of the patterns, causes/effects or changes of
disease conditions in defined populations. They silently work in issues of public health, aiming to identify risk
factors, health policies strategies and tracking their effects along time. For that matter, they help to correctly
design studies, statistical analysis and interpretation of the results. For all these reasons I feel specially close to
epidemiologists and it was such a pleasure to analise a database that could contribute somehow in the scientifical
comunity.
I want to specially thank for all the statistical knowledge that I have been thaught and for making my work
so much easier with the guidance of my final degree project tutor, Joan Valls [7]. Thank you for the time you
invest in me, for the patience and all the support you have given to me. Finally, I would like to thank all the
people I worked with during my stage at IRBLleida and have given me the opportunity to develop my skills in
data analysis.
(a) Composition of the ”Unitat de bioes-
tad´ıstica i epidemiologia” at IRBLleida
(b) Head of the Neuroscience research group
at IRBLleida
1http://www.irblleida.org
2https://www.facebook.com/BiostatsLleida/
3https://clinicalneuroscienceslleida.wordpress.com/
4Epidemiology, literally meaning ”the study of what is upon the people”, is derived from Greek: epi meaning ”upon”, demos
meaning ”people” and logos meaning ”study”.
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2 Introduction
The work presented in this project is within the frame-
work of the descriptive analysis of epidemiological data
on Stroke. More particularly, the analysis in centered
on the assessment on the incidence of Stroke in Lleida
from 2010 to 2014 period and its trend. The incidence
will be studies globally and taking into account age
groups5. The data will be studied taking into account
the sex and specific stroke subtypes.
The stroke is a cardiovascular accident. It happens
when blood flow to a portion the brain is impaired due
to a blood clot or broken blood vessel. Much like a
heart attack, the lack of oxigen-rich blood can lead to
tissue death. When brain cells begin to die as a re-
sult, symptoms occur in the parts of the body that
those brain cells control. These symptoms can include
sudden weakness, paralysis,numbness of face or limbs,
and difficulty to think, move or even breath. It always
have been a lot of controversy on the understanding of
the disease. The first stroke recorded in history was
recognised by Hippocrates, known to be the father of
medicine, more than 2.400 years ago. He called the
condition apoplexy, which is in Greek terms that stands
for ”struck down by violence”. Back in the seventeenth
century, a doctor named Jacob Wepfer discovered that
some of the apoplexy cases were massive bleeding into
the brain, while in other the arteries were blocked.
Nowadays, it is known by the medical community that
stroke can be separated into two groups. Stroke can be
ischemic type -basically due to a loss or reduction of
blood supply to the brain or haemorrhagic type -due to
haemorrhagic rupture of a cerebral vessel-. Regarding
its type, Ischemic stroke have an estimated prevalence
of 85% of the registered cases. Haemorrhagic stroke,
despite a lower prevalence presented -around 15% of
cases of stroke- is associated with mortality and a worse
prognosis.
In terms of epidemiology, stroke is now, according to
the World Health Organization6, the second overall
cause of death in the world and the leading cause of
disability in adults. Epidemiological studies conducted
to date have shown that the incidence increases in de-
veloped countries due course to an increase in life ex-
pectancy, being considered a problem of public health
and being highly prevalent in the elder population
(greater than 80 years), where it became the princi-
pal health problem. The health and economic burden
of disease is also very important, estimated by the Cen-
ters of Disease Control and prevention (CDC)7 with a
total annual costs of 34 billion dollars.
In Catalonia, although some studies have been per-
formed [8], there is no systematic estimation of the in-
cidence of stroke in the population or its recent trend.
To the best of our knowledge, the results of this study
would be able to assess -the impact of the most recent
health policies8. An example of another international
health policies related to stroke is the ACT F.A.S.T [2]
campaign. Launched by the British health authorities
to quickly detect the sympthoms of the stroke and call
emergency services.
Figure 1: Campaign launched by the catalan health authorities in order to sensibilise the population about the
stroke disease.
The structure of the document could be summarised in two main blocks: First, all the methodological framework
used for the analysis will be displayed, followed by the results of the research project analysis and its accurate
interpretation.
5e.g. {<40}, {40-54},{55-70}, {71-80} and {>80}
6http://www.who.int/mediacentre/factsheets/fs310/en/
7http://www.cdc.gov/stroke/facts.htm
8In 2006, began the campaign called ”Codi ictus” designed by the catalan health authorities. The model implemented was an
emergency code to quickly identify the simpthoms of the stroke.
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3 Statistical methods
3.1 Incidence Rate
Incidence rate [3] (the so-called ”crude rate”) from a certain disease, like Stroke, have been used as populational
indicators in epidemiologics in order to analise its trend and to evaluate the impact of new treatments or other
health programs implementations. Usually, the incidence of a certain disease can be aggregated by age groups.
Denote with i the different age groups, i = 1, . . . , I and t the period of time in which this rates have been
observated. For our porpouses, we will consider I = 5 that corresponds to the following five age groups:
{¡40}, . . . , {¿80} and t is considered to be an integer that refers to a certain year.
Let us denote cit the number of cases for the age group i and period t. Let’s assume that cit is a positive integer.
On the other hand, let nit to be the number of people at risk on the period t for the same age group i. Then,
the incidence rate is defined as:
Mit =
cit
nit
Assume that λit is the probability to develope a certain disease for the age group i during period t. Thus, is
usually called the risk of a certain disease. In terms of statistics, cit is considered to be a random variable with
expectancy E[cit] = λitnit = θit. More specifically, the number of cases is considered to be characterised by a
Poisson distribution:
cit ∼ P(θit = λitnit)
Then, Mit is an estimator of λit and can be denoted as Mit = λˆit. In practice, incidence rates are given by
100,000 people, such as rit =
cit
nit
100.000 for a given period t and the age group i. It could be interesting to
have an estimator for all the population, ri, that can be written as:
rt =
∑I
i=1 cit∑I
i=1 nit
As stated before, number of cases are assumed to be distributed as a Poisson random variable cit ∼ P(λitnit),
being submitted to a certain variance. In order to evaluate that variance in our estimations, it is a must to
present the rates with their corresponding confidence intervals. Poisson distribution is known to have the same
mean and variance as:
E(cit) = Var(cit)
Then, we can obtain the variance of the incidence risk Mit as:
Var
(
cit
nit
)
=
Var(cit)
n2it
=
λit
nit
And the variance of the age adjusted rates can be obtained as:
Var(Madjt ) = Var(wtMit) = w
2
tVar(Mit) = w
2
t
λit
nit
Given that λit is always an unkown parameter, as stated before can be estimated it with λˆit =
cit
nit
. At this
point, risk estimator Mt is assumed to be assimptotically normally distributed. The reason is because it is a
sum of independent random variables. Then the distribution of Mt is:
Mit ∼ N
(
λˆt,Var(Mˆit)
)
If we scale the normal variable, we can obtain a confidence interval for ρt = λt100.000 with 1 − α confidence
level as:
ρt ∈
[
rt − z1−α2 105
√
Var(Mit) , rt + z1−α2 10
5
√
Var(Mit)
]
Using the same arguments, the age-specific confidence intervals can be computed subsetting the sample to a
certain age group i. It is worth comment, that main assumption on this procedure is the normal approximation
of the rates. Thus, in practice requires that sample size is big enough. As there is no convention to know when
this criteria is met and sould always be judged by expertise criteria. Furthermore, the Poisson distribution
assumption of the number of cases cit should be checked. In practise, the most common deviation from the
Poisson distribution of the cases could be caused due to overdispersion (σˆ2 > µˆ) on the sample.
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3.2 Age adjusted rate
Sometimes investigators are interested in comparing rates in different years, regions or times. In that cases,
the age of the population could have an insight effect on the comparative of the rates. In other words, the
age structures between populations can be the cause of the observed differences. That’s the main reason why
incidence (or mortality) rates should be standardised when your main interest is comparing it with others.
The most common method is the direct method to adjust the incidence rates. Let’s assume we have a standard
population1, more specifically, the proportional weights wi for each age group i. Thus,
∑I
i=1 wi = 1 and the
age adjusted rates (ASR’s) [3] are:
radjt =
I∑
i=1
wi
cit
nit
100.000 =
I∑
i=1
wirit
Using the arguments exposed in Section 3.1, if we substitute Var(Mit) for Var(M
adj
it ) we obtain the confidence
interval for the age adjusted rates.
3.3 Age-period model
As we seen before cit and nit are the number of cases and the population at risk for a given age group i and
a certain period t. The most common model used to assess the trend is the age-period model [4] and can be
written as:
log
(
E
( cit
nit
))
= αi + βit
The model assume that the risk to develop certain disease is log-linear related with time. For the linear
predictors (αi) and their corresponding slopes (βi), each age group have its own specific effect. This model,
can be integrated in the framework of the generalised linear models [5], with the logarithmic link and the
Exponential family distribution equals to Poisson.
In order to evaluate the trend of the rates for a given disease, the most usuall measure is the Annual Percent
Change (APC) that quantifies the intensity of the annual increase/decrease of the rates. Let ρt = rt100.000,
then the formal definition of the APC is:
APCi =
λit − λi(t−1)
λi(t−1)
With the assumption that the APC remain constant through time and it is different for each age group.
From the model in Section 3.3, can be deduced that λij = e
αi+βit from which allows us to rewrite the formula
of the APC as follows:
APCi =
eαi+βit − eαi+βi(t−1)
eαi+βi(t−1)
= eβi − 1
Then, using the properties of the maximum likelihood estimators, an estimator of the annual percent change can
be obtained as APCi = e
βˆi − 1, where βi is the maximum likelihood estimation for the parameter on the model
in Section 3.3. The variance of βi can be obtained through the model standard estimation as Var(βi) = σ
2
βi
.
Using the properties of the maximum likelihood estimators, we can assume that βi is assimptotically normal
distributed. Therefore, scaling the distribution of the parameter βi we obtain the confidence interval for the
APC such as:
APCi ∈
[
e
βˆi−zα
2
σˆ2βi − 1 , eβˆi+zα2 σˆ2βi − 1
]
Finally, in some cases is interesting to adjust the same slope for each age group. Thus, can be interpreted as
there are no differences in the trend for all age groups. In such cases, the most common model used is the
”age-drift” [4] that can be written as follows:
log
(
E
( cit
nit
))
= α+ βt
Using the same arguments used in the ”age-period” model, APC and their corresponding confidence intervals
can be computed.
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4 Research project
The research project that will be exposed was developed by the Clinical Neuroscience grup at IRBLleida. The
project was named ”Incidence of Stroke in Lleida from 2010 to 2014 period”. Furthermore, this is a test driver
to apply for a medicine research grant that allows us to replicate using data from the whole catalan territory..
First, we will explain about the design of the study, followed by the methodology and finally, we will show the
results of the analysis.
4.1 Design of the study
Observational, population based and cross-sectional study, including patients diagnosed with a Stroke, as pri-
mary or secundary diagnosis in hospitalary discharges registered in Lleida from 2010 to 2014. The inclusion
codes (ICD-10), that will quantify the cases, are those from 430 to 432 (haemorrhagic stroke), from 433 to 435
(ischemic stroke). The data was provided by the informatics of the Hospital Arnau de Vilanova. With regards
to the population of Lleida, the data have been obtained from IDESCAT.
4.2 Statistical methods
The methodology used in this project is in line with another national studies with similar characteristics [1].First
of all, the crude incidence rates will be calculated and then adjusted by age (using the standard population
from World Health Organisation 2001 1). The estimations of the rates will be performed in number of cases
per 100.000 people-year, computing the rates globally, separately by sex, age-groups and Stroke sub-type. Log-
linear models based on the Poisson distribution will be used to estimate the variability and their corresponding
confidence intervals. Age-Period Poisson models with log link will be used to compute the APC (Annual Percent
Change) and their corresponding confidence intervals, including statisticall significance of the change. All the
analysis are performed with R statistical package and taking the statistical significance level at 5% (α = 0.05),
therefore, the estimations for the confidence intervals at 95% confidence.
4.3 Objectives
• To determine the incidence of Stroke in Lleida from 2010 to 2014 and their respective time trend. Globally,
stratifying by Stroke sub-types (Ischemic or Haemorrhagic), Sex and Age-groups.
• To compare the global incidence rate obtained in Lleida with different regions around the world.
• To create a scientific-technical report with the epidmiological and statistical information that will allow
to evaluate the situation of the Stroke in Lleida and be useful for the implementation of Public health
measures, as well as to set up the right policies of the echonomics and sanitary resources, improve the
diagnosis, treatments and the prevention actions of the Stroke.
4.4 Statistical analysis
4.4.1 Graphical representations
Figures 6, 7 and 8 revealed the incidence in stroke in Lleida (from 2010 to 2014 period) in Male, Female and All
population both global and considering age groups, taking into account the Global stroke or stroke subtypes
(Ischemic or Haemorrhagic). These figures can be found in the Supplementary materials (Section 6.1) and we
will use its content later on this document.
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Figure 2: Evolution of the Stroke incidence in Lleida (2010 to 2014). Trend in the Stroke incidence shown,
using the Crude Rate (per 100.000) for Male, Female and All population. Decomposition of the Crude Rate
corresponding into Ischemic and Haemorrhagic stroke subtypes also displayed.
First of all, we will be focused on the crude rate of the global population9. In that sense, Figure 2 depicts the
global incidence rate in Lleida from 2010 to 2014 period. Visual inspection showed no important changes in the
trend of the incidence rates from 2010 to 2014 (considering: men, women and all population). If we consider
stroke subtypes, it can be seen that Ischemic stroke represent most of the cases. Again, no significant trends
can be appreciated in the incidence rates from 2010 to 2014 (considering: men, women and all population).
It can be seen that the incidence of stroke its not the same when taking into account the sex. Indeed, the
incidence is higher in male population.
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Figure 3: Assessment of the trend in Stroke incidence in Lleida (2010-2014). Crude incidence per 100,000
from 2010 to 2014 period shown for sex and stroke subtype. Male, Female and All population displayed in the
first, second and third columns; respectively. Global stroke and their corresponding subtypes (Ischemic and
Haemorrhagic) shown in rows A, B and C; respectively. Annual Percent Change (APC) with 95% confidence
interval displayed. P-values assessing the statistical signification of the trend obtained from Poisson generalised
linear models with logarithmic link. Prediction obtained from models shown in dots and lines.
9e.g. When considering all the population together and do not take into account the age groups.
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Now, we are interested in analise the time trend of the incidence in stroke. Our purpose is to use statistics
methods 10 to decide if the incidence rate is increasing/decreasing or is stable. For that issue, age-period models
were used. More precisely, on Figure 3 contains the trend amongst the sex and the stroke subtypes. It is worth
mention, even though no statistical significant trends were found, the trends were increasing and decreasing for
male and female population, correspondingly. The highest APC (with 95% confidence interval) was found in
Haemorrhagic stroke subtype and male population: APC = 3.61% (-5.15%, 13.21%). The results indicated that
the trend on the incidence rate in stroke was stable (even when considering sex and stroke subtypes).
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Figure 4: Assessment of the trend in Stroke incidence in Lleida (2010-2014) for age groups. Trend in the
Stroke incidence shown, using the Crude Rate (per 100,000) for Male, Female and All population for each age
group threshold (<40, 40-54, 55-70, 71-80, >80). Global stroke and their corresponding subtypes (Ischemic and
Haemorrhagic) displayed from left to right; in A, B and C, correspondingly.
It is known that stroke incidence is not the same accross age groups. According to medical criteriun, it was
decided to use the following age groups for the porpouses of this analysis: {<40, 40-55, 56-70, 71-80, >80}.
Figure 4 depicts the average11 crude rate in stroke for sex and stroke subtypes. The incidence accross the
age groups was found much higher for Ischemic than for Haemorrhagic stroke subtype. It can be seen a clear
association between the age and the incidence rate. More precisely, the higher the age group is, the higher the
crude become. This association was in line with the scientific literature. Again, men showed higher incidence
rate than women for each age group and stroke subtype. No differences can be observer with regards to the
behaviour of the trends in different stroke subtypes.
Figure 5: Global stroke incidence. Age Standardized Rate per 100,000 (World Health Organization 2001 stan-
dard population) shown for several worldwide regions and periods. Estimation for the incidence in Lleida with
darker grey shown
.
10Jointpoint regression models have been carried out to challenge if there is a change on the trend. No statistical results were
obtained
11Since no statistical significant trends were found, it was decided to represent the average of the crude rate between 2010 to
2014 for each age group.
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It was explained, in Section 3.2 that ASR’s (age standardized rates) were used to compare incidence rates coming
from different populations. To achieve that purpouse, direct method was used. It is important to remark ASR’s
are used to rank rates from diferent populations and can not be interpreted for its number12. Figure 5 showed
the ASR in stroke for several regions around the world [6]. In general terms, the ASR of stroke in Lleida is
whithin the expected range, being this result lower than the middle position of the figure.
4.4.2 Results of the analysis
Graphical representations of the analysis were shown in Section 4.4.1, nevertheless an overall view of the results
will be displayed in this Section. The structure is composed by three blocks (All stroke subtypes, Ischemic and
Haemorrhagic stroke subtype) followed by a general review of the analysis:
• When considering all the stroke subtypes, the observed cases were: n = 888, n= 854, n = 852, n = 929
and n = 874 for 2010 to 2014 period, correspondingly. The incidence of stroke is found higher in male
(n = 525, n = 510, n = 519, n = 561 and n = 541) than female (n = 363, n = 344, n = 333, n = 368
and n = 333) population. The estimation of the global trend over time (with 95% confidence interval)
were: APC = 1.88% (-0.82%, 4.66%), APC = -1.11% (-4.35%, 2.24%) and APC = 0.65% (-1.44%, 2.78%)
for Male, Female and All population, respectively. None of them was found statistically significance, so
there is no evidence to reject the stability assumption for the incidence of global stroke. If we consider 5
age groups (<40, 40-55, 56-70, 71-80, >80), the incidence rate of the global stroke increases with the age
(as can be seen in Figure 4). The trend in the 71-80 age group for Female population was found APC
= -9.47% (-14.90%, -3.73%) and showed a clear decrease of approximately 10% yearly (p-value = 0.002)
in the incidence rate. Figure ?? depicts the trend along age groups in global stroke, revealing a decrease
of the APC when increase the age in Males and an increasing of the APC when increasing the age in
Females.
• When considering Ischemic stroke subtype, the observed cases were: n = 813, n= 758, n = 765, n = 842
and n = 791 for 2010 to 2014 period, correspondingly. The incidence of stroke is found higher in male
(n = 487, n = 451, n = 469, n = 512 and n = 490) than female (n = 326, n = 307, n = 296, n = 330
and n = 301) population. The estimation of the global trend over time (with 95% confidence interval)
were: APC = 1.71% (-1.13%, 4.63%), APC = -0.94% (-4.36%, 2.60%) and APC = 0.62% (-1.57%, 2.86%)
for Male, Female and All population, respectively. None of them was found statistically significance, so
there is no evidence to reject the stability assumption for the Ischemic stroke incidence. If we consider 5
age groups (<40, 40-55, 56-70, 71-80, >80), the incidence rate of the global stroke increases with the age
(as can be seen in Figure 4). The trend in the 71-80 age group for Female population was found APC
= -8.72% (-14.46%, -2.64%) and showed a clear decrease of approximately 9% yearly (p-value = 0.006)
in the incidence rate. ?? depicts the trend along age groups in global stroke, revealing a decrease of the
APC when increase the age in Male and an increasing of the APC when increasing the age in Female
population.
• When considering Haemorrhagic stroke subtype, the observed cases were: n = 75, n= 96, n = 87, n = 87
and n = 83 for 2010 to 2014 period, correspondingly. The incidence of stroke is found higher in male (n
= 38, n = 59, n = 50, n = 49 and n = 51) than female (n = 37, n = 37, n = 37, n = 38 and n = 32)
population. It is worth mention that Haemorrhagic stroke, is the minority subtype and only represent the
10% of the global stroke cases (as can be seen in Figure 1). The estimation of the global trend over time
(with 95% confidence interval) were: APC = 3.61% (-5.15%, 13.21%), APC = -2.54% (-12.12%, 8.06%)
and APC = 0.94% (-5.62%, 7.95%) for Male, Female and All population, respectively. None of them was
found statistically significance, so there is no evidence to reject the stability assumption for the Ischemic
stroke incidence. If we consider 5 age groups (<40, 40-55, 56-70, 71-80, >80), the incidence rate of the
global stroke increases with the age (as can be seen in Figure 4). The trend in the age group was not
found statistically significant, so there is no evidence to reject the stability assumption for the incidence
rate. Figure ?? depicts the trend along age groups in global stroke, revealing no clear patterns nor in
Male or Female population.
12An ASR = 95 should not be interpreted as 95 incident cases per 100.000 people. Its only value is to rank populations from
different regions, sex or periods.
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• In general terms, it can be seen a higher incidence of stroke in Male than Female population (even when
considering different stroke subtypes). The incidence rate is found to increase when the age increases
(even when considering stroke subtypes). The statistical power is deficient when analysing Haemorrhagic
stroke subtype (due to lower incidence) and the estimations are not as accurate as the estimations in
global stroke or Ischemic stroke subtype. The incidence of stroke (globally and Ischemic subtype) on
female population between 71-80 years old are found to be decreasing approximately 10% yearly, being
this result statistically significant. With regards to the global trend of stroke is found to be stable in
Male, Female and All population (even when considering different subtypes). The estimated trend in age
groups decreases when the age increases in Male population and increases when the age increases in Female
population (when considering Global and Ischemic stroke subtype). Figure 5 compare the estimated global
Age standardised rate (ASR = 97.83 [77.85, 117.81]) per 100,000 population found in Lleida from 2010 to
2014 with other regions worldwide, showing a plausible result.
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5 Conclusions
In the introduction of this work we exposed the origins of this project, which began when we worked in a
biomedical research project at IRBLleida under the supervision of Joan Valls. That project was designed to
study the incidence of the stroke in Lleida from 2010 to 2014 period. Formal definition and the history of the
stroke disease were provided on the begining of this work. We have been able to define and set which are the
main objectives of the epidemiology. In a nutshell, epidemiology is closed related with medicine but is more
focused on quantify which is the impactt of certain diseases into the whole population. In order to achieve that
goal, epidemiologists need to have a strong statistical background.
We have introduced the most common statistics to study the incidence/death for a given disease, setting the
theoretical framework that we used in the statistical analysis. That is, the incidence rate, age standardised
rates and the Age-period model to evaluate their time trends. We defined their respective confidence intervals
to properly study the variance of our estimators. Our reference in the methodological approach is known to be
the most used amongst the scientifical community [3].
We have defined the characteristics of the study, the methodological approach and its objectives. The study
is observational, retrospective and population-based. Regarding to the statistical framework used, we formally
defined in Section 6.1. On the other hand there are three main objectives of the research project: -To assess
the incidence of the stroke in Lleida from 2010 to 2014 (stratifying by sex, age groups and stroke subtype), -To
assess their trend over time and -To compare the incidence found with other regions of the world.
Some graphical representations were displayed to correctly interpret the results of the statistical analysis in
Section 4.4.1. Furthermore, we summarised all the important information in Figures 6, 7 and 8 and discused
the overall results in 4.4.2. The incidence of Stroke in Lleida from 2010 to 2014 period was characterised by
higher incidence in male population, an increasement of the incidence with the age of the patients. When
considering stroke subtypes, Ischemic stroke was found the most common (more than 90% of the cases) and
the rest corresponds to Haemorrhagic stroke. Regarding to the trend of the incidence, there was no statistical
significance evidence to reject the stability of the incidence from 2010 to 201413. Despite the fact that there
were no statistical significant trends, one can not omit, in terms of descriptive statistics, that the APC was
increasing and decreasing; for male and female population, respectively. Thus, indicates in alignment of the
medical community that no epidemiological outbreaks happenned from 2010 to 2014 in the incidence of stroke
in Lleida. No differences found in the trends with regards to different stroke subtypes.
Finally, we have been able to compare the global age standardised rate estimated in Lleida with different regions
around the world, using the most recent world estimation [6]. The estimated global ASR in Lleida was slightly
below the average of the other regions, indicating that there are no big differences between the analised regions
due to demographics or another risk factors. All in all, the Neuroscience research grup at IRBLleida and us
considered that the analysis results succesfully reflects the objectives of the work. Also, this research project
served as the pilot test to be applied to the whole catalan territory, conditioned to the medical funding grants
available.
With regards to the statistical methodology in this paper, we tried other models that have not been presented
due to lack of adjustment. For the Age-period and the Age-draft models, identity link and Gaussian distribution
had been performed. With regards to the trend, the adjustment of the APC obtained by the Age-period models
assume that there is no change14 in the whole period. For this purpose, jointpoint regression models have been
performed with no statistical significant results. Perhaps, with a bigger period on our data, some changes on
the trends could have been detected.
13Except for Female population with Global or Ischemic stroke subtype within the 70-80 age group.
14e.g. from 2010 to 2012 increasing incidence rate and from 2013 to 2015 decreasing rates
12
Incidence of Stroke in Lleida (2010-2014) Ramon Boix
6 Annex
6.1 Supplementary materials
6.1.1 Global stroke
All stroke subtypes 
 Age groups Global 
Male <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases Crude rate (95% CI) 
Adjusted rate  
(95% CI) 
2010 5 (4.32) 42 (81.57) 129 (409.26) 178 (1179.2) 171 (1632.93) 525 
233.96 
(214.37,254.86) 
129.75 
(118.18,142.83) 
2011 18 (15.66) 52 (98.94) 129 (400.45) 157 (1059.45) 154 (1416.87) 510 
226.28 
(207.06,246.79) 
130.08 
(118.17,143.5) 
2012 9 (7.95) 43 (80.59) 140 (420.71) 154 (1066.78) 173 (1556.18) 519 
230.31 
(210.92,251.01) 
126.55 
(115.19,139.39) 
2013 10 (9.05) 44 (81.81) 166 (487.23) 173 (1223.39) 168 (1482.27) 561 
250.69 
(230.38,272.32) 
140.63 
(128.51,154.23) 
2014 14 (13.03) 53 (98.08) 152 (435.7) 164 (1170.43) 158 (1368.91) 541 
243.81 
(223.7,265.25) 
135.5 
(123.63,148.86) 
 �me trend  �me trend  
APC 
(95% CI) 
11.53 
(-7.40, 34.68) 
1.82 
(-7.02, 11.53) 
3.27 
(-1.95, 8.78) 
1.24 
(-3.52, 6.24) 
-3.05 
(-7.63, 1.76) 
 
1.88 
(-0.82, 4.66) 
 
p-value 0.25 0.7 0.22 0.62 0.21  0.18  
 Age groups Global 
Female <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases Crude rate (95% CI) 
Adjusted rate 
 (95% CI) 
2010 10 (9.63) 23 (51.01) 59 (185.3) 121 (660.16) 150 (921.04) 363 
168.55 
(151.65,186.81) 
72.96 
(64.44,83.1) 
2011 7 (6.75) 22 (47.66) 53 (164.35) 124 (685.99) 138 (821.18) 344 
158.58 
(142.27,176.26) 
67.68 
(59.62,77.31) 
2012 8 (7.77) 17 (36.27) 47 (142.52) 104 (587.01) 157 (915.83) 333 
152.97 
(136.98,170.32) 
61.58 
(53.88,70.85) 
2013 10 (9.87) 29 (61.42) 57 (169.07) 87 (503.44) 185 (1051.91) 368 
169.48 
(152.6,187.71) 
68.73 
(60.45,78.59) 
2014 4 (4.03) 27 (56.72) 60 (175.41) 79 (462.96) 163 (902.2) 333 
154.09 
(137.98,171.56) 
61.26 
(53.66,70.46) 
 �me trend  �me trend  
APC 
(95% CI) 
-9.99 
(-28.35, 12.52) 
-1.11 
(-4.35, 2.24) 
-0.78 
(-8.73, 7.85) 
-9.47 
(-14.90, -3.73) 
2.1 
(-2.81, 7.27) 
 
-1.11 
(-4.35, 2.24) 
 
p-value 0.36 0.51 0.85 0.002 0.41  0.51  
 Age groups Global 
All <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases Crude rate (95% CI) 
Adjusted rate 
 (95% CI) 
2010 15 (6.83) 65 (67.31) 188 (296.72) 299 (894.57) 321 (1199.64) 888 
201.92 
(188.86,215.65) 
99.42 
(92.29,107.32) 
2011 25 (11.44) 74 (74.96) 182 (282.33) 281 (854.23) 292 (1055.14) 854 
193.08 
(180.34,206.47) 
97.61 
(90.41,105.56) 
2012 17  (7.87) 60 (59.87) 187 (282.24) 258 (802.41) 330 (1167.73) 852 
192.31 
(179.61,205.67) 
92.48 
(85.65,100.04) 
2013 20 (9.44) 73 (72.28) 223 (328.99) 260 (827.45) 353 (1220.57) 929 
210.7 
(197.37,224.69) 
102.74 
(95.47,110.75) 
2014 18 (8.71) 80 (78.71) 212 (306.84) 243 (781.95) 321 (1084.13) 874 
199.54 
(186.53,213.22) 
96.64 
(89.63,104.39) 
 �me trend  �me trend  
APC 
(95% CI) 
2.01 
(-11.50, 17.78) 
2.93 
 (-4.42, 10.86) 
2.28 
(-2.14, 5.90) 
-3.00 
(-6.61, 0.74) 
-0.57 
(-3.95, 2.92) 
 
0.65  
(-1,44, 2.78) 
 
p-value 0.78 0.45 0.32 0.12 0.74  0.54  
Figure 6: Incidence of stroke in Lleida (2010-2014). Number of stroke cases, Crude Rate (CR) per 100,000 in
Lleida from 2010 to 2014 displayed for age groups for male female and both sex population. Global estimation
of the cases, CR (95% confidence interval) or ASR (95% confidence interval) for all years also shown for male,
female and both sex population. WHO (World Health Organization 2001) standard population used to compute
the Age standardized Rate. Annual Percent Change (APC) with 95% confidence interval shown for male , female
and both sex population. Poisson models with logarithmic link used to assess the trend and their corresponding
statistical significance.
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6.1.2 Ischemic stroke
 
Ischemic stroke  
 Age groups Global 
Male <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
Crude rate 
 (95% CI) 
Adjusted rate  
(95% CI) 
2010 5 (4.32) 39 (75.75) 116 (368.02) 166 (1099.7) 161 (1537.43) 487 
217.03 
(198.18,237.19) 
119.76 
(108.67,132.35) 
2011 16 (13.92) 38 (72.3) 115 (356.99) 144 (971.73) 138 (1269.67) 451 
200.1 
(182.06,219.45) 
114.1 
(103.02,126.69) 
2012 7 (6.19) 36 (67.47) 128 (384.65) 141 (976.72) 157 (1412.25) 469 
208.13 
(189.71,227.84) 
114.25 
(103.47,126.51) 
2013 7 (6.34) 41 (76.23) 151 (443.21) 158 (1117.32) 155 (1367.57) 512 
228.8 
(209.41,249.5) 
127.49 
(116.03,140.44) 
2014 11 (10.24) 48 (88.83) 135 (386.97) 148 (1056.24) 148 (1282.27) 490 
220.83 
(201.71,241.28) 
121.99 
(110.76,134.71) 
 �me trend  �me trend  
APC (95% CI) 
5.32 
(-14.23,29.48) 
4.11 
(-5.587,14.85) 
3.21 
(-2.28,9.02) 
0.51 
(-4.43,5.70) 
-2.92 
(-7.69,2.10) 
 
1.71 
(-1.13, 4.63) 
 
p-value 0.62 0.42 0.26 0.84 0.25  0.24  
 Age groups Global 
Female <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
Crude rate 
 (95% CI) 
Adjusted rate 
 (95% CI) 
2010 8 (7.7) 17 (37.71) 54 (169.60) 108 (589.23) 139 (853.49) 326 
151.37 
(135.38,168.72) 
64.14 
(56.26,73.65) 
2011 6 (5.79) 18 (39) 49 (151.94) 108 (597.48) 126 (749.78) 307 
141.53 
(126.14,158.28) 
59.9 
(52.37,69.02) 
2012 7 (6.8) 13 (27.74) 41 (124.33) 98 (553.14) 137 (799.16) 296 
135.98 
(120.92,152.38) 
54.53 
(47.33,63.32) 
2013 7 (6.91) 24 (50.83) 50 (148.31) 82 (474.51) 167 (949.57) 330 
151.98 
(136.02,169.29) 
60.4 
(52.73,69.66) 
2014 4 (4.03) 21 (44.11) 53 (154.94) 70 (410.22) 153 (846.85) 301 
139.28 
(123.99,155.94) 
54.05 
(46.96,62.74) 
 �me trend  �me trend  
APC (95% CI) 
-9.43 
(-29.61, 15.86) 
6.46 
(-7.83,23.14) 
-2.06 
(-10.33,6.98) 
-8.72 
(-14.46,-2.64) 
2.28 
(-2.87,7.71) 
 
-0.94 
(-4.36, 2.60) 
 
p-value 0.43 0.4 0.64 0.006 0.39  0.6  
 Age groups Global 
All <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
Crude rate 
 (95% CI) 
Adjusted rate 
 (95% CI) 
2010 13 (5.92) 56 (57.99) 170 (268.31) 274 (819.77) 300 (1121.16) 813 
184.87 
(172.38,198.03) 
90.15 
(83.39,97.66) 
2011 22 (10.07) 56 (56.73) 164 (254.41) 252 (766.07) 264 (953.96) 758 
171.37 
(159.39,184.02) 
85.78 
(79.08,93.23) 
2012 14 (6.48) 49 (48.89) 169 (255.08) 239 (743.32) 294 (1040.34) 765 
172.67 
(160.65,185.36) 
82.88 
(76.43,90.06) 
2013 14 (6.61) 65 (64.36) 201 (296.53) 240 (763.80) 322 (1113.38) 842 
190.97 
(178.28,204.31) 
92.21 
(85.37,99.78) 
2014 15 (7.26) 60 (67.88) 188 (272.1) 218 (701.51) 301 (1016.58) 791 
180.59 
(168.23,193.63) 
86.45 
(79.85,93.8) 
 �me trend  �me trend  
APC (95% CI) 
-1.03 
(-15.50, 15.85) 
4.83 
(-3.32, 13.70) 
1.88 
(-2.74, 6.73) 
-3.11 
(-6.88, 0.81) 
-0.44 
(-3.96, 3.22) 
 
0.62 
(-1.57, 2.86) 
 
p-value 0.9 0.25 0.43 0.12 0.81  0.58  
Figure 7: Incidence of Ischemic stroke in Lleida (2010-2014). Number of stroke cases, Crude Rate (CR) per
100,000 in Lleida from 2010 to 2014 displayed for age groups for male female and both sex population. Global
estimation of the cases, CR (95% confidence interval) or ASR (95% confidence interval) for all years also shown
for male, female and both sex population. WHO (World Health Organization 2001) standard population used
to compute the Age standardized Rate. Annual Percent Change (APC) with 95% confidence interval shown for
male , female and both sex population. Poisson models with logarithmic link used to assess the trend and their
corresponding statistical significance.
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6.1.3 Haemorrhagic stroke
Hemorrhagic stroke  
 Age groups 
Global 
Male <40 40-55 55-70 70-80 >80 
 
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
Crude rate 
 (95% CI) 
Adjusted rate  
(95% CI) 
2010 0 (0) 3 (5.83) 13 (41.24) 12 (79.5) 10 (95.49) 38 
16.93 
(11.98,23.24) 
10 
(6.92,14.92) 
2011 2 (1.74) 14 (26.64) 14 (43.46) 13 (87.73) 16 (147.21) 59 
26.18 
(19.93,33.77) 
15.98 
(11.86,21.87) 
2012 2 (1.77) 7 (13.12) 12 (36.06) 13 (90.05) 16 (143.92) 50 
22.19 
(16.47,29.25) 
12.3 
(8.94,17.4) 
2013 3 (2.72) 3 (5.58) 15 (44.03) 15 (106.07) 13 (114.7) 49 
21.9 
(16.2,28.95) 
13.14 
(9.45,18.6) 
2014 3 (2.79) 5 (9.25) 17 (48.73) 16 (114.19) 10 (86.64) 51 
22.98 
(17.11,30.22) 
13.51 
(9.91,18.85) 
 �me trend  �me trend  
APC (95% CI) 
47.88 
 (-6.26,149.52) 
-11.52 
 (-31.22, 13.18) 
3.84 
 (-11.93, 22.61) 
9.64 
 (-7.21, 29.77) 
-4.57 
 (-19.75, 13.40) 
 3.61 
 (-5.151,13.21) 
 
p-value 0.11 0.33 0.65 0.28 0.59  0.43  
 Age groups Global 
Female <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
Crude rate 
 (95% CI) 
Adjusted rate 
 (95% CI) 
2010 2 (1.93) 6 (13.31) 5 (15.7) 13 (70.93) 11 (67.54) 37 
17.18 
(12.1,23.68) 
8.82 
(5.84,13.81) 
2011 1 (0.96) 4 (8.67) 4 (12.40) 16 (88.52) 12 (71.41) 37 
17.06 
(12.01,23.51) 
7.77 
(5.14,12.36) 
2012 1 (0.97) 4 (8.53) 6 (18.19) 6 (33.87) 20 (116.67) 37 
17.00 
(11.97,23.43) 
7.05 
(4.56,11.5) 
2013 3 (2.96) 5 (10.59) 7 (20.76) 5 (28.93) 18 (102.35) 38 
17.50 
(12.38,24.02) 
8.33 
(5.47,13.16) 
2014 0 (0) 6 (12.6) 7 (20.46) 9 (52.74) 10 (55.35) 32 
14.81 
(10.13,20.9) 
7.21 
(4.68,11.73) 
 �me trend  �me trend  
APC (95% CI) 
-12.49 
 (-50.30, 48.76) 
0.7  
(-23.85, 33.34) 
10.81  
(-14.40, 44.47) 
-16.34  
(-32.01, 2.23) 
0.29 
 (-14.94, 18.33) 
 -2.54  
(-12.12,8.06) 
 
p-value 0.62 0.96 0.44 0.09 0.97  0.63  
 Age groups Global 
All <40 40-55 55-70 70-80 >80  
Year 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
 (Crude rate) 
cases 
Crude rate 
 (95% CI) 
Adjusted rate 
 (95% CI) 
2010 2 (0.91) 9 (9.32) 18 (28.41) 25 (74.8) 21 (78.48) 75 
17.05 
(13.41,21.38) 
9.28 
(7.1,12.34) 
2011 3 (1.37) 18 (18.23) 18 (27.92) 29 (88.16) 28 (101.18) 96 
21.70 
(17.58,26.50) 
11.83 
(9.32,15.21) 
2012 3 (1.39) 11 (10.98) 18 (27.17) 19 (59.09) 36 (127.39) 87 
19.64 
(15.73,24.22) 9.6 (7.46,12.58) 
2013 6 (2.83) 8 (7.92) 22 (32.46) 20 (63.65) 31 (107.19) 87 
19.73 
(15.8,24.34) 
10.54 
(8.18,13.76) 
2014 3 (1.45) 11 (10.82) 24 (34.74) 25 (80.45) 20 (67.55) 83 
18.95 
(15.09,23.49) 
10.19 
(7.96,13.27) 
 �me trend 
 
�me trend  
APC (95% CI) 
17.89 
 (-15.97, 67.88) 
-6.33 
 (-22.21, 12.61) 
5.96 
 (-7.77, 21.90) 
-1.88 
 (-13.68, 11.47) 
-2.08 
 (-13.07, 10.32) 
 0.94 
 (-5.62,7.95) 
 
p-value 0.35 0.49 0.41 0.77 0.73  0.79  
Figure 8: Incidence of Haemorrhagic stroke in Lleida (2010-2014). Number of stroke cases, Crude Rate (CR)
per 100,000 in Lleida from 2010 to 2014 displayed for age groups for male female and both sex population.
Global estimation of the cases, CR (95% confidence interval) or ASR (95% confidence interval) for all years also
shown for male, female and both sex population. WHO (World Health Organization 2001) standard population
used to compute the Age standardized Rate. Annual Percent Change (APC) with 95% confidence interval
shown for male , female and both sex population. Poisson models with logarithmic link used to assess the trend
and their corresponding statistical significance.
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6.1.4 WHO standard population
Age group wi
<40 0.6553
40-54 0.1800
55-69 0.1123
71− 80 0.0315
> 80 0.0212
Table 1: Example of the vector (with four age groups) with the weights of the standard population proposed
by the World Health Organisation in 2001
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